Atopic Dermatitis.

This collection of articles from the Australasian Journal of Dermatology provides information on the efficacy and safety of various treatments for atopic dermatitis (AD). The studies discuss the results of clinical trials and real-world studies on targeted systemic therapies, including lebrikizumab and dupilumab, for moderate-to-severe AD in adults and adolescents. The studies show that both lebrikizumab and dupilumab are effective and safe treatment options for AD. Other articles in the collection explore topics such as the management of sleep disturbance in children with AD, the relationship between AD and mental health, and the association between AD and dementia. These findings provide valuable insights for patients and healthcare professionals seeking effective treatments and management strategies for AD. [Extracted from the article]